C4 Therapeutics, Inc.

3M, C4 Therapeutics, PepsiCo
TradingView · 09 Oct 2026
JPMorgan initiates C4 Therapeutics stock coverage at Overweight
Investing.com · 09 Oct 2026
Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC)
Stock Titan · 02 Oct 2026
Form 4 C4 Therapeutics Inc For: 27 September By Investing.com
Investing.com Canada · 27 Sep 2026
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society Annual Meeting
Investing News Network · 25 Sep 2026
C4 Therapeutics presents cemsidomide trial biomarker data
Investing.com · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.